Document Detail


Increased amounts of von Willebrand factor are bound to microparticles after infusion of desmopressin.
MedLine Citation:
PMID:  23051555     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Effects of desmopressin (DDAVP) in platelet disorders and primary haemostasis cannot be attributed solely to the increase in FVIII/VWF (von Willebrand factor), as VWF/FVIII concentrates have no effect in these circumstances. Microparticles (MP) can support haemostasis by expression of phospholipids, tissue factor and VWF on their surface. We hypothesized that significant amounts of VWF are bound to MP after DDAVP administration and that consequently depletion of MP should influence VWF:Ag and VWF:RCo plasma levels. Platelet-poor plasma was either obtained well from healthy controls or before and after DDAVP administration from patients with von Willebrand's disease (type 1 or possible type 1) or patients with other bleeding disorders as controls. Concentrations of MP and VWF parameters were determined before and after MP depletion by different methods (magnetic bead selection, plasma microfiltration, ultracentrifugation). Platelet MP and VWF-bearing MP were significantly increased after DDAVP. MP depletion by magnetic bead selection led to a significant reduction in VWF:Ag (-18.0%) and VWF:RCo (-27.7%) plasma levels without changes in VWF multimer composition. As results were similar for DDAVP control subjects, the amount of VWF bound to circulating microparticles was significantly higher after DDAVP administration compared with healthy controls (reduction -11.7%). DDAVP leads to a release of microparticles and increases the amount of VWF bound to microparticles which might explain the clinical efficacy of DDAVP in platelet disorders.
Authors:
A Trummer; B Haarmeijer; S Werwitzke; C Wermes; A Ganser; U Budde; A Tiede
Related Documents :
18506005 - Phase 1b randomized study of antidote-controlled modulation of factor ixa activity in p...
11923795 - Glycoprotein iib-iiia inhibition with abciximab and postprocedural risk assessment: les...
16149025 - Use of the platelet reactivity index by grotemeyer, platelet function analyzer, and ret...
19618315 - Thrombin formation and platelet activation at the site of vascular injury in patients w...
15172625 - Effects of high platelet concentration in collecting and freezing dry platelets concent...
16825935 - A simple approach to noninvasively identifying significant fibrosis in chronic hepatiti...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-11
Journal Detail:
Title:  Haemophilia : the official journal of the World Federation of Hemophilia     Volume:  -     ISSN:  1365-2516     ISO Abbreviation:  Haemophilia     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9442916     Medline TA:  Haemophilia     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 Blackwell Publishing Ltd.
Affiliation:
Department of Haematology, Haemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Understanding intra-neighborhood patterns in PM2.5 and PM10 using mobile monitoring in Braddock, PA.
Next Document:  Quantitative trait loci for resistance to Haemonchus contortus artificial challenge in Red Maasai an...